ToxTree: descriptor-based machine learning models for both hERG and Nav1.5 cardiotoxicity liability predictions
Drug-mediated blockade of the voltage-gated potassium channel(hERG) and the voltage-gated sodium channel (Nav1.5) can lead to severe cardiovascular complications. This rising concern has been reflected in the drug development arena, as the frequent emergence of cardiotoxicity from many approved drugs led to either discontinuing their use or, in some cases, their withdrawal from the market. Predicting potential hERG and Nav1.5 blockers at the outset of the drug discovery process can resolve this problem and can, therefore, decrease the time and expensive cost of developing safe drugs. One fast and cost-effective approach is to use in silico predictive methods to weed out potential hERG and Nav1.5 blockers at the early stages of drug development. Here, we introduce two robust 2D descriptor-based QSAR predictive models for both hERG and Nav1.5 liability predictions. The machine learning models were trained for both regression, predicting the potency value of a drug, and multiclass classification at three different potency cut-offs (i.e. 1$\mu$M, 10$\mu$M, and 30$\mu$M), where ToxTree-hERG Classifier, a pipeline of Random Forest models, was trained on a large curated dataset of 8380 unique molecular compounds. Whereas ToxTree-Nav1.5 Classifier, a pipeline of kernelized SVM models, was trained on a large manually curated set of 1550 unique compounds retrieved from both ChEMBL and PubChem publicly available bioactivity databases. The proposed hERG inducer outperformed most metrics of the state-of-the-art published model and other existing tools. Additionally, we are introducing the first Nav1.5 liability predictive model achieving a Q4 = 74.9% and a binary classification of Q2 = 86.7% with MCC = 71.2% evaluated on an external test set of 173 unique compounds. The curated datasets used in this project are made publicly available to the research community.
Code (0)
등록된 구현이 없습니다.
Tasks
Binary ClassificationDrug DiscoveryMethods 이 논문이 사용한 방법론
Similar Papers 제목 키워드 기반
Virtual Screening of Pharmaceutical Compounds with hERG Inhibitory Activity (Cardiotoxicity) using Ensemble Learning
In silico prediction of cardiotoxicity with high sensitivity and specificity for potential drug molecules can be of immense value. Hence, building machine learning classification models, based on some features extracted …
BIG-bench Machine LearningDrug DiscoveryEnsemble LearningPrediction+1Virtual screening of DrugBank database for hERG blockers using topological Laplacian-assisted AI models
The human {\it ether-a-go-go} (hERG) potassium channel (K$_\text{v}11.1$) plays a critical role in mediating cardiac action potential. The blockade of this ion channel can potentially lead fatal disorder and/or long QT s…
Drug DiscoveryCardioGenAI: A Machine Learning-Based Framework for Re-Engineering Drugs for Reduced hERG Liability
The link between in vitro hERG ion channel inhibition and subsequent in vivo QT interval prolongation, a critical risk factor for the development of arrythmias such as Torsade de Pointes, is so well established that in v…
Drug DiscoveryPredicting Cancer Treatments Induced Cardiotoxicity of Breast Cancer Patients
Cardiotoxicity induced by the breast cancer treatments (i.e., chemotherapy, targeted therapy and radiation therapy) is a significant problem for breast cancer patients. The cardiotoxicity risk for breast cancer patients …
Evaluating Skill and Stability of ArchesWeather and ArchesWeatherGen under Multi-Decadal Climate Simulations
We evaluate the climate simulation capabilities of ArchesWeather and ArchesWeatherGen, two machine learning models originally trained for weather forecasting and evaluated up to a 10-day lead time. ArchesWeather is a det…
Weather Forecasting